Exagen Inc. XGN Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $68.38M+20.6% | $66.58M+19.7% | $63.6M+14.1% | $58.86M+3.9% | $56.72M+1.8% | ||
| $28.5M+23.5% | $27.78M+23.3% | $25.53M+11.1% | $23.89M+3.2% | $23.09M+0.5% | ||
| $39.88M+18.6% | $38.8M+17.2% | $38.07M+16.1% | $34.98M+4.4% | $33.64M+2.7% | ||
| 58.3%-1.0pp | 58.3%-1.2pp | 59.9%+1.1pp | 59.4%+0.3pp | 59.3%+0.5pp | ||
| $6.52M+16.5% | $6.25M+16.4% | $6.15M+28.3% | $5.9M+25.2% | $5.6M+16.7% | ||
| $47.48M+12.9% | $46.62M+12.7% | $44.4M+2.3% | $43.11M-3.3% | $42.04M-8.8% | ||
| $54M+13.4% | $52.87M+13.1% | $50.55M+44.9% | $49.02M+17.5% | $47.64M-3.1% | ||
| -$14.12M-0.9% | -$14.07M-3.2% | -$12.48M+19.0% | -$14.04M+11.2% | -$14M+22.8% | ||
| -20.6%+4.0pp | -21.1%+3.4pp | -19.6%+8.0pp | -23.9%+4.0pp | -24.7%+7.9pp | ||
| $5.04M+126% | $4.32M+93.3% | $3.55M+58.7% | $2.79M+25.2% | $2.23M-0.7% | ||
| —— | —— | —— | —— | —— | ||
| $87K+625% | $51K+325% | $50K+506% | $49K+197% | $12K-51.5% | ||
| -$20.17M-30.0% | -$19.95M-32.0% | -$19.04M-12.5% | -$16.98M+1.9% | -$15.51M+19.9% | ||
| -29.5%-2.2pp | -30%-2.8pp | -29.9%+0.4pp | -28.8%+1.7pp | -27.3%+7.4pp | ||
| -$0.89-6.0% | -$0.92-10.8% | -$0.92+2.1% | -$0.89+8.2% | -$0.84+22.9% | ||
| -$14.12M-0.9% | -$14.07M-3.2% | -$12.48M+19.0% | -$14.04M+11.2% | -$14M+22.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Exagen Inc.'s revenue?
- Exagen Inc. (XGN) generated $68.4M in revenue over the trailing twelve months, up 20.5% year over year.
- Is Exagen Inc. profitable?
- Exagen Inc. is not currently profitable: it reported a net loss of $20.2M over the trailing twelve months, a -29.5% net margin.
- What are Exagen Inc.'s profit margins?
- Gross margin is 58.3% and operating margin is -20.6%, with a -29.5% net margin.
- What is Exagen Inc.'s earnings per share?
- Exagen Inc.'s diluted EPS over the trailing twelve months is $-0.89.
- Where does Exagen Inc.'s income statement data come from?
- Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
